For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| Anastrazole-clomiphene-placebo | anastrozole for eight weeks then clomiphene for eight weeks then placebo for eight weeks Anastrozole 1mg Clomiphene Citrate 25mg Placebo - Cap | 0 | None | 0 | 4 | 2 | 4 | View |
| Anastrazole-placebo-clomiphene | anastrozole for eight weeks then placebo for eight weeks then clomiphene for eight weeks Anastrozole 1mg Clomiphene Citrate 25mg Placebo - Cap | 0 | None | 0 | 4 | 1 | 4 | View |
| Clomiphene-anastrazole-placebo | clomiphene for eight weeks then anastrozole for eight weeks then placebo for eight weeks Anastrozole 1mg Clomiphene Citrate 25mg Placebo - Cap | 0 | None | 0 | 4 | 1 | 4 | View |
| Clomiphene-placebo-anastrazole | clomiphene for eight weeks then placebo for eight weeks then anastrozole for eight weeks Anastrozole 1mg Clomiphene Citrate 25mg Placebo - Cap | 0 | None | 0 | 4 | 1 | 4 | View |
| Placebo-clomiphene-anastrazole | placebo for eight weeks then clomiphene for eight weeks then anastrozole for eight weeks Anastrozole 1mg Clomiphene Citrate 25mg Placebo - Cap | 0 | None | 1 | 4 | 1 | 4 | View |
| Placebo-anastrazole-clomiphene | placebo for eight weeks then anastrozole for eight weeks then clomiphene for eight weeks Anastrozole 1mg Clomiphene Citrate 25mg Placebo - Cap | 0 | None | 0 | 4 | 3 | 4 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Lyme Disease | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Headache | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Osteopenia | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | None | View |
| Rib Pain | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | None | View |
| Left Shoulder Pain | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | None | View |
| Upper Respiratory Infection (URI) | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Vitamin D deficiency | SYSTEMATIC_ASSESSMENT | Endocrine disorders | None | View |
| Dizziness | SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| Insomnia | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Fatigue | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Weight Gain | SYSTEMATIC_ASSESSMENT | Endocrine disorders | None | View |
| Decreased Libido | SYSTEMATIC_ASSESSMENT | Endocrine disorders | None | View |
| Chronic Maxillary Sinusitis | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |
| Right Big Toe Pain | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | None | View |
| Ringworm | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Nasal Septal Deviation | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Bloated | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |